Hedge Fund - Slate Path Capital
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $138,940,366 | 2.4% | 8,289,998 | $16.14 |
| 2 | 2025 - Q1 (2025-03-31) | $148,412,689 | 2.68% | 9,655,998 | $17.86 |
| 3 | 2024 - Q4 (2024-12-31) | $187,142,367 | 3.38% | 8,491,033 | $18.19 |
| 4 | 2024 - Q3 (2024-09-30) | $246,301,559 | 3.79% | 13,668,233 | $17.50 |
| 5 | 2024 - Q2 (2024-06-30) | $328,106,740 | 6.24% | 20,191,184 | $15.40 |
| 6 | 2024 - Q1 (2024-03-31) | $379,505,156 | 7.52% | 26,896,184 | $12.61 |
| 7 | 2023 - Q4 (2023-12-31) | $273,853,561 | 6.07% | 26,231,184 | $9.34 |
| 8 | 2023 - Q3 (2023-09-30) | $243,208,800 | 6.77% | 23,844,000 | $9.31 |
| 9 | 2023 - Q2 (2023-06-30) | $93,650,610 | 3.42% | 12,437,000 | $8.11 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center